Ni
Non verificato

Niagen Bioscience, Inc

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaSaluteScienza
13/11/2025
Multimedialità
Cosmesi
E-commerce
Pubblico Esercizio/Vendita al dettaglio
Luxury
Salute
Industria
Niagen Bioscience Launches Tru Niagen® Beauty — The First NAD+ Skincare Supplement in the U.S. Featuring Niagen® (Patented Nicotinamide Riboside)
1.00
13/11/2025
Scienza
Psichiatria
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Biotecnologia
Farmaceutica
Salute
Industria
Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID
1.00
06/11/2025
Salute
Sanità
Scienza
Farmaceutica
Biotecnologia
Finanza
Niagen Bioscience Announces $10 Million Share Repurchase Program
1.00
04/11/2025
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Sanità
Salute
Farmaceutica
Niagen Bioscience, Inc. Reports Third Quarter 2025 Financial Results and Reaffirms Increased Full Year Outlook
1.00
21/10/2025
Biotecnologia
Sanità
Salute
Farmaceutica
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Niagen Bioscience to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
1.00
06/10/2025
Salute
Pubblico Esercizio/Vendita al dettaglio
Niagen Bioscience Increases Full Year 2025 Net Sales Outlook to 25% to 30% Year-Over-Year Growth
1.00
01/10/2025
Multimedialità
Terza età
Fitness
Biotecnologia
Sanità
Farmaceutica
Vetrine/Shopping
Salute
Industria
Niagen Bioscience's Pharmaceutical-Grade Niagen™ IV and Injections Now Available at over 50 iCRYO Clinics and More than 900 Total Clinics Nationwide
1.00
16/09/2025
Tecnica
Fitness
Biotecnologia
Web e Social Network
Scuola/Istruzione
Farmaceutica
Salute
Information Technology
Industria
AboutNADⓇ Debuts as the Leading Online Resource for Scientific Advancements in NAD+
1.00
04/08/2025
Biotecnologia
Salute
Scienza
Farmaceutica
Eventi
Web e Social Network
Niagen Bioscience to Present at Canaccord Genuity’s 45th Annual Growth Conference
1.00
23/07/2025
Biotecnologia
Salute
Scienza
Farmaceutica
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Niagen Bioscience to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0